HYPR
NASDAQ
US
Hyperfine, Inc. - Class A Common Stock
$1.13
▲ +$0.04
(+3.67%)
Vol 221K
4
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$95.2M
ROE
-103.9%
Margin
-378.2%
D/E
0.00
Beta
1.10
52W
$1–$2
Wall Street Consensus
8 analysts · Apr 20262
Strong Buy
5
Buy
1
Hold
0
Sell
0
Strong Sell
87.5%
Buy Rating
Price Chart
Similar Stocks
Earnings
Beat rate: 40.0%
Next Report
May 11, 2026
EPS Estimate: $-0.09
| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Mar 2026 | $-0.09 | — | — |
| Dec 2025 | $-0.08 | $-0.05 | +$0.03 |
| Sep 2025 | $-0.11 | $-0.11 | $0.00 |
| Jun 2025 | $-0.12 | $-0.12 | +$0.00 |
Quarterly Revenue & Earnings
| Quarter | 2024-0… | 2024-1… | 2025-0… | 2025-0… | 2025-0… |
|---|---|---|---|---|---|
| Revenue | $3.6M | $2.3M | $2.1M | $2.7M | $3.4M |
| Net Income | -$10.3M | -$10.4M | -$9.4M | -$9.2M | -$11.0M |
Fundamentals Trend
| Metric | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | -84.8% | -74.2% | -84.8% | -84.8% | -84.8% | -103.9% |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | -342.2% | -343.4% | -364.5% | -364.5% | -364.5% | -378.2% |
| Gross Margin | 49.3% | 46.2% | 45.8% | 45.8% | 45.8% | 46.1% |
| D/E Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Current Ratio | 5.02 | 6.07 | 5.02 | 5.02 | 5.02 | 3.63 |
Key Ratios
ROA (TTM)
-80.5%
P/S (TTM)
8.98
P/B
1.3
EPS (TTM)
$-0.52
Rev Growth 3Y
+105.0%
52W High
$2.22
52W Low
$0.53
$0.53
52-Week Range
$2.22
Financial Health
Free Cash Flow
-$5.7M
Net Debt
-$21.4M
Cash
$21.6M
Total Debt
$182K
As of Sep 30, 2025
How does HYPR compare to Health Care peers?
Peer group: Micro-cap Health Care (All) · 241 companies
HYPR valuation vs Health Care peers
P/E ratio
—
▼
0%
below
peers
(30.7)
vs Peers
vs Industry
Undervalued
P/S ratio
9.0
▲
248%
above
peers
(2.6)
vs Peers
vs Industry
Overvalued
P/B ratio
1.3
▼
53%
below
peers
(2.8)
vs Peers
vs Industry
Undervalued
Div yield
—
▼
0%
below
peers
(0.7%)
vs Peers
vs Industry
Low yield
HYPR profitability vs Health Care peers
ROE
-103.9%
▼
170%
below
peers
(-38.5%)
vs Peers
vs Industry
Weak
Net margin
-378.2%
▼
1432%
below
peers
(-24.7%)
vs Peers
vs Industry
Weak
Gross margin
46.1%
▼
13%
below
peers
(52.9%)
vs Peers
vs Industry
Weak
ROA
-80.5%
▼
279%
below
peers
(-21.2%)
vs Peers
vs Industry
Weak
HYPR financial health vs Health Care peers
D/E ratio
0.0
▼
100%
below
peers
(19.3)
vs Peers
vs Industry
Low debt
Current ratio
3.6
▲
68%
above
peers
(2.2)
vs Peers
vs Industry
Below avg
Beta
1.1
▲
5%
above
peers
(1.1)
vs Peers
vs Industry
Less volatile
HYPR fundamentals radar
HYPR
Peer median
Industry
HYPR profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
HYPR vs peers: key metrics
Insider Activity
NeutralBuys
0
Sells
0
HALE BRETT
Chief Financial Officer · Mar 23
24188 shs
TEISSEYRE THOMAS
Chief Operating Officer · Mar 23
24188 shs
TEISSEYRE THOMAS
Chief Operating Officer · Feb 13
821 shs
Last 90 days
Top Holders
Top 5: 12.16%Vanguard Group Inc
4.35%
$4.0M
Sio Capital Management, LLC
2.44%
$2.2M
Fosun International Ltd
2.12%
$1.9M
Northern Trust Corporation
1.64%
$1.5M
Catalio Capital Management,…
1.61%
$1.5M
As of Dec 31, 2025
Latest News
No related news yet